Us Bancorp »

Avalo Therapeutics Ord shares owned by Us Bancorp

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Us Bancorp from 13F filings

Historical chart of Us Bancorp investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Us Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Us Bancorp

Quarter filed Position value Share count Share price at filing
2025-12-31 $50k 2.7k 18.16

More positions owned by Us Bancorp

NVIDIA Corporation Call Option (NVDA)
Apple Put Option (AAPL)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Ishares Tr Core Us Aggbd Et (AGG)
Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Core Msci Emkt (IEMG)
Alphabet Cap Stk Cl A (GOOGL)
Vanguard Index Fds Mid Cap Etf (VO)
Amazon (AMZN)
Ishares Tr Rus Mid Cap Etf (IWR)
Ishares Tr Eafe Value Etf (EFV)
Ishares Tr Core Msci Total (IXUS)
Automatic Data Processing Put Option (ADP)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Us Bancorp

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
Silverarc Capital Management
RA Capital Management
Marshall Wace
Citadel Advisors
TCG Crossover Management
Commodore Capital
UBS Group

View all funds holding Avalo Therapeutics Ord